Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.

Background: The wearable cardioverter-defibrillator (WCD) has emerged as a valuable tool to temporarily protect patients at risk for sudden cardiac death (SCD). The aim of this study was to determine the value of the WCD for therapy optimization of heart failure patients.

Methods: One hundred five consecutive patients that received WCD between 4/2012 and 9/2016 were included in the study.